本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Revolution Medicines, Inc.

204.86
-0.2500-0.12%
盤後204.50-0.3600-0.18%19:34 EDT
成交量:126.88萬
成交額:2.58億
市值:439.09億
市盈率:-22.96
高:207.00
開:206.98
低:200.24
收:205.11
52周最高:224.31
52周最低:42.18
股本:2.14億
流通股本:1.85億
量比:0.90
換手率:0.69%
股息:- -
股息率:- -
每股收益(TTM):-8.9212
每股收益(LYR):-5.9502
淨資產收益率:-79.09%
總資產收益率:-30.12%
市淨率:16.85
市盈率(LYR):-34.43

資料載入中...

2023/02/27

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/27

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/13

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/06

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/23

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/01/10

重要事件披露

8-K - Current report
2022/12/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/12/07

重要事件披露

8-K - Current report
2022/11/07

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/11/07

重要事件披露

8-K - Current report
2022/09/30

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/09/01

重要事件披露

8-K - Current report
2022/08/09

重要事件披露

8-K - Current report
2022/08/09

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/07/22

重要事件披露

8-K - Current report
2022/07/13

重要事件披露

8-K - Current report
2022/06/27

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals